Identification of Actionable Mutations in Metastatic Castration-Resistant Prostate Cancer Through Circulating Tumor DNA: Are We There Yet?
Simple Summary: Metastatic castration-resistant prostate cancer (mCRPC) refers to prostate cancer that has spread to distant organs and no longer responds to androgen deprivation therapy. Despite the availability of treatments that can alleviate symptoms and modestly extend survival, it remains an i...
| Publicado en: | Current Oncology Vol. 32; no. 12; pp. 692 - 710 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Dec2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |